Servier CDMO

Integrated Drug Substance & Drug Product Manufacturing and Packaging Services – CDMO

Investment Opportunities for an HPAPI CDMO

Our research team conducted an in-depth assessment of HPAPI CDMOs in the European market, focusing on those with OEB levels 4 and higher. This analysis provided Servier with the critical insights needed to make well-informed, data-driven investment decisions. By identifying potential partners, evaluating market gaps, and exploring opportunities for vertical integration or expansion in the high-potency sector, Servier was able to strategically position itself for growth and leadership in this specialized market.

Investment Opportunities for an HPAPI CDMO